On the other hand, although it is described in the literature that PSMA is highly expressed in the tumour tissue of >80% of patients with PCa (67–71), the distribution of PSMA-avid lesions and the fraction of PSMA-negative lesions are unique for each individual patient. This evidence concerns the gene FOLH1 and posterior cortical atrophy.